US-Based National Institutes of Health Launches Clinical Trial Of Universal Influenza Vaccine Candidate
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus strains has begun at the…
Share